boceprevir News
Most Popular boceprevir Story
Merck scoots past Vertex in blockbuster race for hep C drug approval
Merck ($MRK) has stolen a small lead in its hot race with Vertex ($VRTX) for regulatory approval of a new hepatitis C treatment. The pharma giant says that regulators in the U.S. as well as Europe Read more...
Latest Headlines
- May 20, 2011
- April 27, 2011
- April 25, 2011
- March 31, 2011
- August 4, 2010
- April 23, 2009
- August 4, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
